Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

Stainer L, Ryder S, Carr E, Collins C, Arora M, Tolley K. : A structured expert elicitation exercise conducted with UK clinicians to inform and validate inputs for a cost-effectiveness analysis of Filsuvez® gel (birch bark extract) in epidermolysis bullosa. Poster CO106. Presented at: ISPOR Europe 2023; 12-15 November 2023; Copenhagen, Denmark.